Tedaviden Sonra

Aşağıdaki konulardan seçim yapın:

Referanslar

1. Muhn C, et al. Clin Cosmet Investig Dermatol. 2012;5:147–58. 2. Lin ZY, et al. Plas Aesthet Res. 2016:3:72–82. 3. Chiu A, et al. J Drugs Dermatol. 2016;15(9):1076–82. 4. Raspaldo H. J Cos Laser Ther. 2008;10:134–42. 5. Jones D and Murphy DK. Dermatol Surg. 2013;39:1–11. 6. Allergan. Unpublished Data. INT/0297/2017. Juvéderm® VOLITE Clinical Study (V12-001), 9 months topline summary. Apr 2017. 7. Goodman GJ, et al. Clin Cos Invest Dermatol. 2011;4:197–205. 8. Kablik J, et al. Dermatol Surg. 2009;35:302–12. 9. McCullough JL and Kelly KM. Ann NY Acad Sci. 2006;1067:323–31. 10. Papakonstantinou E, et al. Dermatoendocrinol. 2012;4(3):253–58. 11. Allergan. DOF INT/0771/2016(2). Juvéderm is the world’s leading HA brand. Feb 2019. 12. Hee CK et al. Dermatol Surg. 2015;41(Suppl 1):S373–81. 13. Eccleston D and Murphy DK. Clin Cosmet Investig Dermatol. 2012;5:167–72. 14. Juvéderm® VOLIFTTM with lidocaine DFU. 72383JR14. Revision 2017-07-19. 15. Juvéderm® VOLUMATM with lidocaine DFU. 72475JR13. Revision 2017-07-19. 16. Juvéderm® VOLBELLATM with lidocaine DFU. 72525JR12. Revision 2017-07-19. 17. Juvéderm® ULTRA PLUSTM XC DFU. 72361EC12. Revision 2016-02-23. 18. Beer K. Dermatol Clin. 2009;27(4):427–32. 19. De Maio M and Loghem J. Beauty Through Science 2012. International Aesthetics 20. Juvéderm® VOLITETM DFU. 73140JR11. Revision 2017-07-19. 21. Juvéderm® VOLUXTM DFU. 72778JR10. Revision 2018-07-26. 22. Juvéderm® ULTRATM XC DFU. 72360EC12. Revision 2016-02-23. 23. Juvéderm® ULTRA 2 DFU. 72345JR15. Revision 2017-07-19. 24. Juvéderm® ULTRA 3 DFU. 72490JR13. Revision 2017-07-19. 25. Juvéderm® ULTRA 4 DFU. 72488JR13. Revision 2016-07-19. 26. Allergan. Data on File. INT/0683/2017. Global Aesthetics Market Study. Aug 2017. 27. Stephens H. 2000. Allergan’s first fifty years. Lyme, Conn: Greenwich Pub. Group. 28. Goodman GJ, et al. Plast Reconstr Surg. 2015;136:139–48S 29. Brandt FS and Cazzaniga A. Clin Interv Aging. 2008;3(1):153–59. 30. Allemann IB and Baumann L. Clin Interv Aging. 2008;3(4):629–34. 31. Borelli C and Berneburg M. JDDG. 2010;8:326-30. 32. Fischer TC. J Cos Derm. 2010;9:291–96. 33. Jones D and Murphy DK. Dermatol Surg. 2013;39:111. 34. Allergan. Unpublished Data. INT/0297/2017. Juvéderm® VOLITE Clinical Study (V12- 001), 9 months topline summary. Apr 2017. 35. Allergan. Data on File. INT/0773/2016(1). Juvéderm® VOLITE B without lidocaine. Sep 2018. 36. Carruthers A et al. Am Soc Dermatol Surg. 2008;34:167–72. 37. Carruthers A et al. Am Soc Dermatol Surg. 2008;34:167–72. 38. American Society of Plastic Surgeons. Dermal Fillers. Your dermal fillers consultation. 2018. Available at: https://www.plasticsurgery.org/cosmetic-procedures/facial-implants/consultation . Accessed March 2019. 39. NHS Choices. Dermal fillers. Last reviewed May 2016. Available at:https://www.nhs.uk/conditions/cosmetic-treatments/dermal-fillers. Accessed March 2019. 40. Philipp-Dormston WG et al. J Cosmet Dermatol. 2014;13:125–34. 41. Philipp-Dormston WG et al. J Cosmet Dermatol. 2014;13:125–34. 42. Vedamurthy M et al. J Cutan Aesthet Surg. 2010;3(1):11–15. 43. Brandt FS and Cazzaniga A. Clin Interv Aging. 2008; 3(1):153–59. 44. Allemann IB and Baumann L. Clin Interv Aging. 2008; 3(4):629–34.